Reuters logo
BRIEF-Codexis Inc, Nestlé Health Science enter strategic collaboration​
October 12, 2017 / 12:24 PM / 2 months ago

BRIEF-Codexis Inc, Nestlé Health Science enter strategic collaboration​

Oct 12 (Reuters) - Codexis Inc

* Codexis Inc - ‍co, Nestlé Health Science enter strategic collaboration​

* Codexis Inc - ‍Codexis receives an upfront payment of $14 million and potential milestones and royalties depending on product success for deal​

* Codexis Inc - deal ‍includes an option for global development of CDX-6114 for PKU​

* Codexis Inc - ‍Codexis will be responsible for clinical development costs for CDX-6114 up to and including Phase 1 in healthy volunteers​

* Codexis - after ‍phase 1, Nestlé health science will have option to obtain exclusive global license to CDX-6114

* Codexis - after ‍Phase 1, Nestlé health science will be responsible for all future development and commercialization of CDX-6114​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below